SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Axonics, Inc. (AXNX) , forward earnings yield 1.69%. PEG 1.10.
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 59.2
- PEG Ratio 1.10 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Analyst consensus target $71.00 (+0% upside) — modest upside expected.
Overall SharesGrow Score: 52/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AXNX
Valuation Multiples
P/E (TTM)0.0
Forward P/E59.2
PEG Ratio1.10
Forward PEG1.10
P/B Ratio0.00
P/S Ratio9.51
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.12
Forward EPS (Est.)$1.20
Book Value / Share$0.00
Revenue / Share$7.46
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield1.69%
Dividend Yield0.00%
Analyst Target$71.00 (+0%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.95 |
$0.00 |
$-17.4M |
- |
| 2017 |
$-0.97 |
$128.12K |
$-18.06M |
-14097% |
| 2018 |
$-4.64 |
$707K |
$-32.48M |
-4594.5% |
| 2019 |
$-2.80 |
$13.82M |
$-79.94M |
-578.4% |
| 2020 |
$-1.48 |
$111.54M |
$-54.92M |
-49.2% |
| 2021 |
$-1.86 |
$180.29M |
$-80.07M |
-44.4% |
| 2022 |
$-1.28 |
$273.7M |
$-59.7M |
-21.8% |
| 2023 |
$-0.12 |
$366.38M |
$-6.09M |
-1.7% |
